HalfLifeDBEvidence before certainty.

MXE evidence profile

The MXE records describe a toxicity case and analytical metabolism or detectability work.

Category: dissociative · Updated: August 7, 2026

Sources and model notes are maintained by . This page is educational, not clinical guidance. Corrections: admin@halflifedb.co.

Model statusNo curve publishedCurrent sources do not support one defensible human input
Evidence boundarySource note onlyNo animal, forensic, mixture, or proxy value is presented as a human half-life
Model scopeNot modeledThe profile explains what the available records can and cannot establish
References3Linked studies, labels, reviews, or identity records described below

MXE: evidence and interpretation notes

Why HalfLifeDB does not plot MXE

The MXE records describe a toxicity case and analytical metabolism or detectability work. Neither provides a representative controlled human elimination half-life for methoxetamine.

MXE has a sparse evidence base compared with approved medicines. The available citations are more toxicology and detectability oriented than clean therapeutic pharmacokinetic labels.

The citations include analytically confirmed toxicity cases, metabolism/detectability research, and the compound record.

For MXE, parent-compound decline can differ from dissociation, sedation, analgesia, or motor effects. Metabolites and redistribution may also be relevant depending on the substance.

What each source contributes

  • Menzies EL et al. Methoxetamine-associated reversible cerebellar toxicity (2012). This supporting literature record adds compound-specific background and is used only within the limits of its design.
  • Meyer MR et al. Methoxetamine metabolism and toxicological detectability (2013). This metabolism study identifies pathways, metabolites, or analytical targets and does not by itself create a complete human concentration-time curve.
  • PubChem: Methoxetamine. This identity record confirms names and compound identity and does not supply a human half-life.

For MXE, the decision to withhold a curve turns on the limits visible in Menzies EL et al. Methoxetamine-associated reversible cerebellar toxicity (2012). This supporting literature record adds compound-specific background, but it is used only within the limits of its design.

What evidence would change the page

The next useful evidence for MXE would be a direct human pharmacokinetic study with a defined exposure context and sufficient late sampling. Without that, converting Menzies EL et al. Methoxetamine-associated reversible cerebellar toxicity (2012) into a first-order midpoint would overstate what its design can support.

InterpretationCategory context and evidence limits

dissociative context

Dissociative entries often require care because parent compounds, metabolites, redistribution, and subjective duration may not move together.

  • The calculator does not model active metabolites separately.
  • Duration and half-life can diverge substantially.
  • Study values may depend on route and sampling window.
EvidenceSource trail and model decision

Sources and evidence context

A linked record is not automatically proof of the displayed value. Study, labeling, review, and compound identity sources serve different purposes; notes below identify limitations when they are known.

2 PubMed0 PMC0 DailyMed1 PubChem
  1. Research abstract Menzies EL et al. Methoxetamine-associated reversible cerebellar toxicity (2012).
    Supporting literature record. Its role and study design should be read from the linked source before applying any numerical finding.
  2. Research abstract Meyer MR et al. Methoxetamine metabolism and toxicological detectability (2013).
    Metabolism-focused evidence used to identify pathways or analytes. It does not automatically establish a population half-life.
  3. Identity record PubChem Compound Summary: Methoxetamine.
    Compound identity and naming record. It supplies chemistry context, not independent numerical support for the model.
BoundariesWhat this page cannot answer and where to continue

What this page does not answer

  • It does not estimate impairment, intoxication, or fitness to drive.
  • It does not predict urine, blood, saliva, or hair test results.
  • It does not model repeated exposure, tolerance, withdrawal, or interactions.
  • It does not replace clinician, pharmacist, toxicologist, or emergency guidance.

Continue with context

Read the medical disclaimer, methodology, and research standards before using the model for comparison.